These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34818875)

  • 21. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
    Nishino M; Miura S; Yoshioka A; Kuwahara I; Nishimura T; Hamada K; Fukui H
    Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
    Nesbitt IM; Goodeve AC; Preston FE; Peake IR
    Thromb Haemost; 1996 Nov; 76(5):820-1. PubMed ID: 8950801
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets.
    Suzuki H; Shima M; Kamisue S; Nakai H; Nogami K; Shibata M; Morichika S; Tanaka I; Giddings JC; Yoshioka A
    Thromb Res; 1998 Jun; 90(5):207-14. PubMed ID: 9694242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New variant of von Willebrand disease with defective binding to factor VIII.
    Nishino M; Girma JP; Rothschild C; Fressinaud E; Meyer D
    Blood; 1989 Oct; 74(5):1591-9. PubMed ID: 2506947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
    Karlman M; Holmström M; Wiman B
    Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of factor VIII and von Willebrand factor and the identification of type 2N von Willebrand disease.
    Favaloro EJ
    Thromb Res; 2011 Jan; 127(1):2-3. PubMed ID: 21084106
    [No Abstract]   [Full Text] [Related]  

  • 29. [Variant type von Willebrand disease with defective binding to factor VIII].
    Shima M
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534
    [No Abstract]   [Full Text] [Related]  

  • 30. Big piece, little piece or: yes, factor VIII is a protein.
    Owen WG
    J Thromb Haemost; 2005 Sep; 3(9):1905-9. PubMed ID: 16102092
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular mechanism and classification of von Willebrand disease.
    Sadler JE; Matsushita T; Dong Z; Tuley EA; Westfield LA
    Thromb Haemost; 1995 Jul; 74(1):161-6. PubMed ID: 8578450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C; Miesbach W
    Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired factor VIII and von Willebrand factor (aFVIII/VWF) deficiency and hypothyroidism in a case with hypopituitarism.
    Oliveira MC; Kramer CK; Marroni CP; Leães CG; Viana L; Roithman S; Schmaedecke A; Pereira-Lima JF
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):107-9. PubMed ID: 18550587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease.
    Trossaërt M; Flaujac C; Jeanpierre E; Drillaud N; Sigaud M; Fouassier M; Ternisien C; de Raucourt E
    Haemophilia; 2020 Mar; 26(2):e44-e48. PubMed ID: 31865618
    [No Abstract]   [Full Text] [Related]  

  • 37. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
    Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
    Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy.
    Nishino M; Nishino S; Sugimoto M; Shibata M; Tsuji S; Yoshioka A
    Int J Hematol; 1996 Aug; 64(2):127-34. PubMed ID: 8854570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
    Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
    Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nature of factor VIII.
    Peake IR
    Clin Sci (Lond); 1984 Dec; 67(6):561-7. PubMed ID: 6435936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.